The latest GOLD report also suggests considering the use of diagnostic biomarkers (troponin and NT-proBNP, which are released from cardiac myocytes in response to ischaemia and stretch, respectively) to assess for the contribution of heart failure, MI, and arrhythmia to suspected ECOPD [15]. Here, NPPB is linked to heart failure.